Abstract
The hypoxia-inducible enzyme carbonic anhydrase IX (CA IX) has recently been discussed as a surrogate marker of tumor hypoxia, an indicator of prognosis and a potential therapeutic target in malignant glioma. To characterize patterns of expression of CA IX in human malignant glioma cells, we studied CA IX protein, CA9 mRNA and hypoxia-inducible factor-1α (HIF-1α) protein levels in U87-MG, U251, U373 and GaMG cells exposed to in vitro hypoxia (1, 6 or 24 h at 5%, 1% or 0.1% O2). All cell lines displayed a strong hypoxic induction of CA9 mRNA in response to prolonged severe hypoxia with cell-line specific patterns at moderate to mild hypoxia and shorter treatment times. Only U87-MG exhibited a strong constitutive, normoxic expression of CA IX protein without a detectable change under hypoxia. In U251 and GaMG cell lines, a marked induction of CA IX protein in response to severe hypoxia was seen. CA IX changes under severe hypoxia and the inhibitory effect of the glycolysis inhibitor iodoacetate (IAA, 50 µM) on hypoxic CA IX overexpression were paralleled by the results for HIF-1α protein. Therefore, immunohistochemical CA IX staining in human malignant glioma specimens can result from low oxygen concentrations or constitutive, oncogene-related, overexpression both of which may be prognostically relevant.
Similar content being viewed by others
References
Höckel M, Schlenger K, Aral B, Mitze M, Schaffer U, Vaupel P (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 56:4509–4515
Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz L, Dewhirst MW (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res 56:941–943
Huang LE, Arany Z, Livingston DM, Bunn HF (1996) Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its α subunit. J Biol Chem 271:32253–32259
Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L (1997) Activation of hypoxia-inducible factor 1α: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci USA 94:5667–5672
Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93:1137–1343
Pastorek J, Pastorekova S, Callebaut I, Mornon JP, Zelnik V, Opavskky R, Zatovicova M, Liao S, Portetelle D, Stanbridge EJ, Zavada J, Burny A, Kettmann R (1994) Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9:2788–2888
Zavada J, Zavadova Z, Pastorekova S, Ciampor F, Pastorek J, Zelník V (1993) Expression of MaTu–MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54:268–274
Pastorekova S, Zavada J (2004) Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy. Cancer Ther 2:245–262
Hilvo M, Rafajova M, Pastorekova S, Pastorek J, Parkkila S (2004) Expression of carbonic anhydrase IX in mouse tissues. J Histochem Cytochem 52:1313–1322
Ivanov S, Liao SY, Ivanova A, Danilkovich-Miagkova A, Tarasova N, Weirich G, Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ (2001) Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am J Pathol 158:905–919
Collingridge DR, Piepmaier JM, Rockwell S, Knisely JP (1999) Polarographic measurements of oxygen tension in human glioma and surrounding peritumoural brain tissue. Radiother Oncol 53:127–131
Evans SM, Judy KD, Dunphy I, Jenkins WT, Hwang WT, Nelson PT, Lustig RA, Jenkins K, Magarelli DP, Hahn SM, Collins RA, Grady MS, Koch CJ (2004) Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10:8177–8184
Vordermark D (2005) Significance of hypoxia in malignant glioma. Re: Evans et al. Hypoxia is important in the biology and aggression of human glial brain tumors. Clin Cancer Res 10:8177–8184; Clin Cancer Res 11:3966–3967
Proescholdt MA, Mayer C, Kubitza M, Schubert T, Liao SY, Stanbridge EJ, Ivanov S, Oldfield EH, Brawanski A, Merrill MJ (2005) Expression of hypoxia-inducible carbonic anhydrases in brain tumors. Neuro-oncol 7:465–475
Haapasalo JA, Nordfors KM, Hilvo M, Rantala IJ, Soini Y, Parkkila AK, Pastorekova S, Pastorek J, Parkkila SM, Haapsalo HK (2006) Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis. Clin Cancer Res 12:473–477
Akslen LA, Andersen KJ, Bjerkvig R (1988) Characteristics of human and rat glioma cells grown in a defined medium. Anticancer Res 8:797–803
Vordermark D, Katzer A, Baier K, Kraft P, Flentje M (2004) Cell-type-specific association of hypoxia-inducible factor-1alpha (HIF-1alpha) protein accumulation and radiobiologic tumor hypoxia. Int J Radiat Oncol Biol Phys 58:1242–1250
Vordermark D, Kaffer A, Riedl S, Katzer A, Flentje M (2005) Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells. Int J Radiat Oncol Biol Phys 61:1197–1207
Chomczynski P, Sacchi V (1987) Single-step method of RNA isolation by acidic guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159
Said HM, Katzer A, Flentje M, Vordermark D (2005) Response of the plasma hypoxia marker osteopontin to in vitro hypoxia in human tumor cells. Radiother Oncol 76:200–205
Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47
Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732
Wykoff C, Beasley N, Watson P, Turner L, Pastorek J, Wilson G, Turley H, Maxwell P, Pugh C, Ratcliffe P, Harris A (2000) Hypoxia-inducible regulation of tumor-associated carbonic anhydrases. Cancer Res 60:7075–7083
Olive PL, Aquino-Parsons C, MacPhail SH, Liao SY, Raleigh JA, Lerman MI, Stanbridge EJ (2001) Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61:8924–8929
Svastová E, Hulíková A, Rafajová M, Zatovicová M, Gibadulinová A, Casini A, Cecchi A, Scozzafava A, Supuran CT, Pastorek J, Pastoreková S (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH. FEBS Lett 577:439–445
Ito H, Kanzawa T, Miyoshi T, Hirohata S, Kyo S, Iwamaru A, Aoki H, Kondo Y, Kondo S (2005) Therapeutic efficacy of PUMA for malignant glioma cells regardless of p53 status. Hum Gene Ther 16:685–698
Posch MG, Zang C, Mueller W, Lass U, von Deimling A, Elstner E (2004) Somatic mutations in peroxisome proliferator-activated receptor-gamma are rare events in human cancer cells. Med Sci Monit 10:BR250–BR254
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954
Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG (1999) Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9:469–479
Shinoura N, Sakurai S, Shibasaki F, Asai A, Kirino T, Hamada H (2002) Co-transduction of Apaf-1 and caspase-9 highly enhances p53-mediated apoptosis in gliomas. Br J Cancer 86:587–595
Kaluzova M, Pastorekova S, Pastorek J, Kaluz S (2000) p53 tumour suppressor modulates transcription of the TATA-less gene coding for the tumour-associated carbonic anhydrase MN/CA IX in MaTu cells. Biochim Biophys Acta 1491:20–26
Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, DePinho RA (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15:1311–1333
Kaur B, Tan C, Brat DJ, Post DE, Van Meir EG (2004) Genetic and hypoxic regulation of angiogenesis in gliomas. J Neuro-oncol 70:229–243
Ivanov SV, Kuzmin I, Wei MH, Pack S, Geil L, Johnson BE, Stanbridge EJ, Lerman MI (1998) Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes. Proc Natl Acad Sci USA 95:12596–12601
Bishop JM (1987) The molecular genetics of cancer. Science 235:305–311
Prendergast GC, Cole MD (1989) Posttranscriptional regulation of cellular gene expression by the c-myc oncogene. Mol Cell Biol 9:124–134
Koukourakis MI, Bentzen SM, Giatromanolaki A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E, Harris AL (2006) Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 24:727–735
Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS (2003) Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9:802–811
Parkkila S, Rajaniemi H, Parkkila AK, Kivelä J, Waheed A, Pastoreková S, Pastorek J, Sly WS (2000) Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci 5:2220–2224
Chrastina A, Pastorekova S, Pastorek J (2003) Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody. Neoplasma 50:13–21
Semenza GL, Roth PH, Fang H-M, Wang LW (1994) Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 269:23757–23763
Holbrook JJ, Liljas A, Steindel SJ, Rossman MG (1975), Lactate dehydrogenase. In: Boyer PD (eds) The enzymes. Volume 11, 3rd ed. Academic Press, NY, pp 191–292
Harris RA, Bowker-Kinley MM, Hyang B, Wu P (2002) Regulation of the activity of the pyruvate dehydrogenase complex. Adv Enzyme Regul 42:249–259
Schmaltz C, Hardenbergh PH, Wells A, Fisher DE (1998) Regulation of proliferation—survival decisions during tumor cell hypoxia. Mol Cell Biol 18:2845–2854
Vordermark D, Kraft P, Katzer A, Bolling T, Willner J, Flentje M (2005) Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1alpha (HIF-1alpha). Cancer Lett 230:122–133
Staab , Löffler J, Katzer A, Beyer M, Said HM, Polat B, Einsele H, Flentje M, Vordermark D, Modulation of glucose metabolism inhibits hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α) (submitted)
Acknowledgements
This work was supported in part by a grant from the Deutsche Forschungsgemeinschaft (to DV) and by IZKF Wuerzburg (to CH and GHV). We thank Prof. Dr. Ulf Rapp, MSZ Institute, University of Würzburg, for the possibility to use the radioactivity laboratories and Bayer Healthcare Co. for provision of the M75 monoclonal antibody.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Said, H.M., Staab, A., Hagemann, C. et al. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. J Neurooncol 81, 27–38 (2007). https://doi.org/10.1007/s11060-006-9205-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-006-9205-2